PETSPETMED EXPRESS INC

Nasdaq 1800petmeds.com


$ 4.15 $ -0.54 (-11.46 %)    

Wednesday, 12-Jun-2024 15:59:55 EDT
QQQ $ 476.76 $ 6.13 (1.31 %)
DIA $ 387.57 $ -0.28 (-0.07 %)
SPY $ 541.15 $ 4.41 (0.82 %)
TLT $ 92.53 $ 0.69 (0.75 %)
GLD $ 214.71 $ 0.57 (0.27 %)
$ 4.17
$ 4.18
$ 4.16 x 400
$ 0.00 x 0
$ 4.11 - $ 4.20
$ 3.92 - $ 14.73
949,946
na
85.17M
$ 0.37
nm
TBD
na
na ($ 0.29)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-15-2024 12-31-2023 10-Q
2 10-31-2023 09-30-2023 10-Q
3 08-01-2023 06-30-2023 10-Q
4 05-23-2023 03-31-2023 10-K
5 02-07-2023 12-31-2022 10-Q
6 11-08-2022 09-30-2022 10-Q
7 08-02-2022 06-30-2022 10-Q
8 05-24-2022 03-31-2022 10-K
9 02-04-2022 12-31-2021 10-Q
10 11-02-2021 09-30-2021 10-Q
11 07-30-2021 06-30-2021 10-Q
12 05-25-2021 03-31-2021 10-K
13 01-26-2021 12-31-2020 10-Q
14 11-03-2020 09-30-2020 10-Q
15 08-03-2020 06-30-2020 10-Q
16 05-26-2020 03-31-2020 10-K
17 01-28-2020 12-31-2019 10-Q
18 10-30-2019 09-30-2019 10-Q
19 07-30-2019 06-30-2019 10-Q
20 05-28-2019 03-31-2019 10-K
21 01-29-2019 12-31-2018 10-Q
22 10-30-2018 09-30-2018 10-Q
23 07-31-2018 06-30-2018 10-Q
24 05-29-2018 03-31-2018 10-K
25 01-30-2018 12-31-2017 10-Q
26 10-31-2017 09-30-2017 10-Q
27 07-31-2017 06-30-2017 10-Q
28 05-23-2017 03-31-2017 10-K
29 01-31-2017 12-31-2016 10-Q
30 11-01-2016 09-30-2016 10-Q
31 08-01-2016 06-30-2016 10-Q
32 05-24-2016 03-31-2016 10-K
33 02-02-2016 12-31-2015 10-Q
34 10-27-2015 09-30-2015 10-Q
35 07-28-2015 06-30-2015 10-Q
36 05-22-2015 03-31-2015 10-K
37 01-26-2015 12-31-2014 10-Q
38 10-28-2014 09-30-2014 10-Q
39 07-29-2014 06-30-2014 10-Q
40 05-27-2014 03-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-maintains-buy-on-petmed-express-lowers-price-target-to-7

Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the price target from $9 to $7.

 morgan-stanley-maintains-underweight-on-petmed-express-lowers-price-target-to-35

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target fro...

 petmed-express-q4-2024-gaap-eps-025-misses-007-estimate-sales-66504m-beat-65000m-estimate

PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0....

 petmed-express-announces-caroline-conegliano-appointed-as-coo-announces-cfo-transition-christine-chambers-will-leave-the-company-in-early-august-2024-after-the-company-has-filed-its-q1-2025-report

Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology OfficerCompany Announ...

 petmed-express-q3-2024-eps-010-misses-001-estimate-sales-65317m-beat-65000m-estimate

PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0....

 petmeds-announces-selected-preliminary-q3-financial-results-sees-q3-revenue-653m-vs-68m-est

PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds" or the "Company"), Your Trusted Pet Health ExpertTM, today announ...

 earnings-scheduled-for-february-8-2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

 petmeds-express-inc--has-appointed-leslie-c-g-campbell-as-chairman-of-the-board-effective-january-5-2024-succeeds-dr-gian-fulgoni-who-will-remain-on-the-board-and-will-also-continue-to-chair-the-boards-corporate-governance-and-nominating-committee

As part of the PetMeds Express, Inc. Board of Directors' ("Board") ongoing Board composition and succession plannin...